Cargando…

Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT

BACKGROUND: Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of...

Descripción completa

Detalles Bibliográficos
Autores principales: Um, Jihye, Chun, Byung Chul, Lee, Yeong Seon, Hwang, Kyu Jam, Yang, Dong-Kun, Park, Jun-Sun, Kim, Su Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755941/
https://www.ncbi.nlm.nih.gov/pubmed/29267277
http://dx.doi.org/10.1371/journal.pntd.0006084
_version_ 1783290662763888640
author Um, Jihye
Chun, Byung Chul
Lee, Yeong Seon
Hwang, Kyu Jam
Yang, Dong-Kun
Park, Jun-Sun
Kim, Su Yeon
author_facet Um, Jihye
Chun, Byung Chul
Lee, Yeong Seon
Hwang, Kyu Jam
Yang, Dong-Kun
Park, Jun-Sun
Kim, Su Yeon
author_sort Um, Jihye
collection PubMed
description BACKGROUND: Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizing antibodies after vaccination. Here, we report the development of a new monoclonal antibody (mAb) designed to react specifically with Rabies virus (RABV) phosphoprotein (P protein), and the evaluation of its applicability to the RFFIT and its effectiveness as a diagnostic reagent for human rabies. METHODOLOGY/PRINCIPAL FINDINGS: The mAb KGH P 16B8 was produced to target the P protein of the Korean KGH RABV strain. An indirect immunofluorescence assay (IFA) was conducted to detect various strains of RABV in various cell lines. Alexa-conjugated KGH P 16B8 (16B8-Alexa) was developed for the RFFIT. The IFA test could detect RABV up to a 1:2,500 dilution, with a detection limit comparable to that of a commercial diagnostic reagent. The sensitivity, specificity, positive predictive value, and negative predictive value of the RFFIT using 16B8-Alexa in 414 clinical specimens were 98.67%, 99.47%, 99.55%, and 98.42%, respectively. The results of the RFFIT with 16B8-Alexa were strongly correlated with those obtained using an existing commercial diagnostic reagent (r = 0.995, p<0.001). CONCLUSIONS/SIGNIFICANCE: The mAb developed in this study shows high sensitivity and specificity, confirming its clinical utility with the RFFIT to measure the rabies neutralizing antibody titer and establish a diagnosis in human. Thus, 16B8-Alexa is expected to serve as an alternative diagnostic reagent that is widely accessible, with potentially broad applications beyond those of the RFFIT in Korea. Further studies with 16B8-Alexa should provide insight into the immunological mechanism of the P protein of Korean RABV.
format Online
Article
Text
id pubmed-5755941
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57559412018-01-26 Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT Um, Jihye Chun, Byung Chul Lee, Yeong Seon Hwang, Kyu Jam Yang, Dong-Kun Park, Jun-Sun Kim, Su Yeon PLoS Negl Trop Dis Research Article BACKGROUND: Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizing antibodies after vaccination. Here, we report the development of a new monoclonal antibody (mAb) designed to react specifically with Rabies virus (RABV) phosphoprotein (P protein), and the evaluation of its applicability to the RFFIT and its effectiveness as a diagnostic reagent for human rabies. METHODOLOGY/PRINCIPAL FINDINGS: The mAb KGH P 16B8 was produced to target the P protein of the Korean KGH RABV strain. An indirect immunofluorescence assay (IFA) was conducted to detect various strains of RABV in various cell lines. Alexa-conjugated KGH P 16B8 (16B8-Alexa) was developed for the RFFIT. The IFA test could detect RABV up to a 1:2,500 dilution, with a detection limit comparable to that of a commercial diagnostic reagent. The sensitivity, specificity, positive predictive value, and negative predictive value of the RFFIT using 16B8-Alexa in 414 clinical specimens were 98.67%, 99.47%, 99.55%, and 98.42%, respectively. The results of the RFFIT with 16B8-Alexa were strongly correlated with those obtained using an existing commercial diagnostic reagent (r = 0.995, p<0.001). CONCLUSIONS/SIGNIFICANCE: The mAb developed in this study shows high sensitivity and specificity, confirming its clinical utility with the RFFIT to measure the rabies neutralizing antibody titer and establish a diagnosis in human. Thus, 16B8-Alexa is expected to serve as an alternative diagnostic reagent that is widely accessible, with potentially broad applications beyond those of the RFFIT in Korea. Further studies with 16B8-Alexa should provide insight into the immunological mechanism of the P protein of Korean RABV. Public Library of Science 2017-12-21 /pmc/articles/PMC5755941/ /pubmed/29267277 http://dx.doi.org/10.1371/journal.pntd.0006084 Text en © 2017 Um et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Um, Jihye
Chun, Byung Chul
Lee, Yeong Seon
Hwang, Kyu Jam
Yang, Dong-Kun
Park, Jun-Sun
Kim, Su Yeon
Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
title Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
title_full Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
title_fullStr Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
title_full_unstemmed Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
title_short Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
title_sort development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using rffit
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755941/
https://www.ncbi.nlm.nih.gov/pubmed/29267277
http://dx.doi.org/10.1371/journal.pntd.0006084
work_keys_str_mv AT umjihye developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT chunbyungchul developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT leeyeongseon developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT hwangkyujam developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT yangdongkun developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT parkjunsun developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT kimsuyeon developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit